Paolo Carlo C Colombo, MD

Dr. Nir Uriel, an internationally recognized leader in heart failure, mechanical circulatory support, and heart transplantation, has been named Director of Advanced Heart Failure and Cardiac Transplantation at NewYork-Presbyterian. Dr. Uriel will oversee heart failure programs at NewYork-Presbyterians campuses in Manhattan, Queens, Brooklyn, and Westchester, with a goal to increase accessibility of care for those with advanced heart failure throughout the New York area. Dr. Uriel was born and raised in Israel, where he attended medical school. After serving for four years as a physician in the Israeli Defense Forces, he then completed his cardiology residency and fellowship. In 2008, he moved to New York to pursue fellowships at NewYork- Presbyterian/Columbia in cardiology, heart failure, transplant, and mechanical circulatory support and remained here as a faculty member until 2014. He then served as the Louis Block Professor of Medicine and Director of Heart Failure, Transplant and Mechanical Circulatory Support at the University of Chicago Medicine, where, in 2018, he and his Chicago team made history performing two tripleorgan transplants within 27 hours.A dedicated researcher with more than 200 peer-reviewed publications, Dr. Uriel has improved treatment protocols for patients with end-stage heart failure and has extended criteria for the use of ventricular assist devices and eligibility for transplant for high-risk patients, including those who are HIV positive. His research continues with a focus on interactions of medical devices, such as VADS, with the human body.

Dr. Gabriel Sayer is the Associate Director of Advanced Heart Failure, Cardiac Transplantation and Mechanical Circulatory support at NewYork-Presbyterian. In this role, Dr. Sayer provides leadership and oversight for the comprehensive heart failure services provided across NewYork-Presbyterian, including the campuses in Manhattan, Queens, Brooklyn and Westchester. Dr. Sayer attended medical school at the University of Pennsylvania, followed by Internal Medicine residency at Columbia University Irving Medical Center. He completed Cardiology fellowship at Mount Sinai Medical Center and his Advanced Heart Failure fellowship at Massachusetts General Hospital. Prior to joining NewYork-Presbyterian in 2019, Dr. Sayer worked at the University of Chicago for six years, where he was the Associate Director of the Heart Failure, Mechanical Circulatory Support and Cardiac Transplantation programs. In addition to his extensive clinical experience in all aspects of heart failure, Dr. Sayer has published nearly 100 peer-reviewed articles in the field of advanced heart failure. His research interests include the impact of of heart failure treatments on cardiac physiology, with a particular interest in the interaction between patients and mechanical circulatory support devices.https://youtu.be/vT5s8orP6V8

Dr. Emily J. Tsai is the Florence Irving Associate Professor of Medicine at Columbia University Vagelos Colleges of Physicians and Surgeons and an attending physician at the Center for Advanced Cardiac Care of New York-Presbyterian Hospital at Columbia University Irving Medical Center. Board-certified in Cardiovascular Medicine and Advanced Heart Failure and Transplant Cardiology, Dr. Tsai specializes in caring for heart failure patients who require, or who have received, a ventricular assist device or heart transplant.Dr. Tsai is a magna cum laude graduate in engineering sciences of Harvard College and a cum laude graduate of Harvard Medical School and the Harvard-MIT Division of Health Sciences and Technology Program. She completed internal medicine residency training at the Hospital of the University of Pennsylvania and then cardiology fellowship and advanced heart failure and transplant cardiology training at The Johns Hopkins Hospital. As a Ruth L. Kirschstein National Research Service Awardee, Dr. Tsai completed post-doctoral basic cardiovascular research training at Johns Hopkins University in the laboratory of Dr. David A. Kass. After fellowship training, Dr. Tsai was recruited to Temple University School of Medicine as an assistant professor of medicine and physiology and a principal investigator in its Cardiovascular Research Center. In 2015, Dr. Tsai joined the faculty of Columbia University College of Physicians & Surgeons and established her laboratory in molecular and integrative cardiac pathophysiology.As a physician-scientist, Dr. Tsai studies the molecular and cellular biology of heart failure with the goal of developing novel therapies. Major areas of research in Dr. Tsais laboratory include the signaling of soluble guanylyl cyclase (the nitric oxide receptor) in the heart, right heart dysfunction, and cardiac complications associated with COVID-19. Dr. Tsai has been nationally recognized for her scientific achievements by the American College of Cardiology and the Heart Failure Society of America, with their respective Presidential Career Development Award and Jay N. Cohn New Investigator in Basic Sciences Award. She has been awarded several research grants from the National Institutes of Health, American Heart Association, Foundation of Gender Specific Medicine, and the Columbia University Provosts Grants Program. Dr. Tsai has served on national committees of the American College of Cardiology, American Heart Association, and Heart Failure Society of America.